NCT00213512View on ClinicalTrials.gov

Effect of Anti CD20 in Pemphigus Desease

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

October 31, 2008

Conditions

Pemphigus

Interventions

DRUG

Mabthera

Trial Locations (1)

76000

UH-Rouen, Rouen

All Listed Sponsors

lead

University Hospital, Rouen

OTHER

NCT00213512 - Effect of Anti CD20 in Pemphigus Desease | Biotech Hunter | Biotech Hunter